Predictors of Early (0-7 Days) and Late (8-30 Days) Readmission in a Cohort of Acute Coronary Syndrome Patients
Keywords:Myocardial Infarction, Unstable angina, Atrial fibrilation, Intensive care unit, Heart failure, Patient readmission
Background: Readmissions following acute coronary syndrome are unevenly distributed across the 30-day post-discharge period. There is limited data on predictors of all-cause readmission in early (0-7 day) and late (8-30 day) post-discharge periods for this population; the purpose of this retrospective cohort study was to identify predictors of early and late readmission.
Methods: Patients at Michigan Medicine (Ann Arbor, Michigan, United States) with a principal discharge diagnosis of unstable angina, ST-segment elevation myocardial infarction, or non-ST segment elevation myocardial infarction between April 2008 and November 2017 were identified. Predictors of early and late readmission were analyzed with multivariable logistic regression models.
Results: Of 1120 patients hospitalized following acute coronary syndrome, 198 (17.68%) were readmitted within 30 days while 70 (6.25%) were readmitted within 7 days of discharge. Of 30-day readmissions, early readmissions were more likely in females [OR 2.26, 95% confidence interval (CI) 1.23, 4.16], non-white individuals (p=0.05), or patients requiring intensive care unit admission during hospitalization (OR 2.20, 95% CI 1.14, 4.24). Relative to patients not readmitted within 7 days, patients who were female, had history of atrial fibrillation, principal discharge diagnosis of non-ST segment elevation myocardial infarction, or required intensive care unit admission were more likely readmitted early. History of congestive heart failure was a predictor of late readmission when compared to patients not readmitted in 30 days.
Conclusion: Following acute coronary syndrome, predictors of readmission varied between early and late readmission groups. Readmission predictors provides healthcare providers with information useful in minimizing readmissions and concomitant financial penalties.
Dharmarajan K, Hsieh AF, Lin Z, Bueno H, Ross JS, Horwitz LI, et al. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA - J Am Med Assoc. 2013;309(4):355-363.
Dreyer RP, Ranasinghe I, Wang Y, Dharmarajan K, Murugiah K, Nuti SV, et al. Sex differences in the rate, timing, and principal diagnoses of 30-day readmissions in younger patients with acute myocardial infarction. Circulation. 2015;132(3):158-166.
Ranasinghe I, Wang Y, Dharmarajan K, Hsieh AF, Bernheim SM, Krumholz HM. Readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia among young and middle-aged adults: a retrospective observational cohort study. PLoS Med. 2014;11(9):e1001737.
Kwok CS, Wong CW, Shufflebotham H, Brindley L, Fatima T, Shufflebotham A, et al. Early readmissions after acute myocardial infarction. Am J Cardiol. 2017;120(5):723-728.
Graham KL, Dike O, Doctoroff L, Jupiter M, Vanka A, Davis RB, et al. Preventability of early vs. late readmissions in an academic medical center. PLoS One. 2017;12(6):e0178718.
Graham KL, Auerbach AD, Schnipper JL, Flanders SA, Kim CS, Robinson EJ, et al. Preventability of early versus late hospital readmissions in a national cohort of general medicine patients. Ann Intern Med. 2018;168(11):766-774.
Fudim M, O’Connor CM, Dunning A, Ambrosy AP, Armstrong PW, Coles A, et al. Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ascend-hf. Eur J Heart Fail. 2018;20(2):304-314.
Centers for Medicare & Medicaid Services. Readmissions Reduction Program (HRPP). Available from: https://www.cms.gov/medicare/medicare-fee-for-service-payment/acuteinpatientpps/readmissions-reduction-program.html. Last updated August 6th, 2021; cited May 25th, 2021.
Bumpus SM, Krallman R, Kline-Rogers E, Montgomery D, Eagle KA, Rubenfire M. Transitional care to reduce cardiac readmissions: 5-year results from the bridge clinic. J Fam Med Dis Prev. 2017;3(3):3-9.
Bumpus SM, Brush BL, Pressler SJ, Wheeler J, Eagle KA, Rubenfire M. A transitional care model for patients with acute coronary syndrome. Am J Accountable Care. 2014;2(2):39-52.
United States Census Bureau. QuickFacts: Michigan. Available from: https://www.census.gov/quickfacts/fact/table/MI/INC110219. Last updated: unknown. Cited May 25th, 2021.
Chang CM, Yin WY, Wei CK, Wu CC, Su YC, Yu CH, et al. Adjusted age-adjusted charlson comorbidity index score as a risk measure of perioperative mortality before cancer surgery. PLoS One. 2016;11(2):e0148076.
O’Brien C, Valsdottir L, Wasfy JH, Strom JB, Secemsky EA, Wang Y, et al. Comparison of 30-day readmission rates after hospitalization for acute myocardial infarction in men versus women. Am J Cardiol. 2017;120(7):1070-1076.
Khera R, Jain S, Pandey A, Agusala V, Kumbhani DJ, Das SR, et al. Comparison of readmission rates after acute myocardial infarction in 3 patient age groups (18 to 44, 45 to 64, and ?65 years) in the united states. Am J Cardiol. 2017;120(10):1761-1767.
Nguyen OK, Makam AN, Clark C, Zhang S, Das SR, Halm EA. Predicting 30-day hospital readmissions in acute myocardial infarction: the ami “readmits” (renal function, elevated brain natriuretic peptide, age, diabetes mellitus, nonmale sex, intervention with timely percutaneous coronary intervention, and low systolic blood pressure) score. J Am Heart Assoc. 2018;7(8):e008882.
Lemor A, Hernandez GA, Patel N, Blumer V, Sud K, Cohen MG, et al. Predictors and etiologies of 30-day readmissions in patients with non-st-elevation acute coronary syndrome. Catheter Cardiovasc Interv. 2018;93(3):373-379.
Dreyer RP, Dharmarajan K, Kennedy KF, Jones PG, Vaccarino V, Murugiah K, et al. Sex differences in 1-year all-cause rehospitalization in patients after acute myocardial infarction: a prospective observational study. Circulation. 2017;135(6):521-531.
Hess CN, Kaltenbach LA, Doll JA, Cohen DJ, Peterson ED, Wang TY. Race and sex differences in post-myocardial infarction angina frequency and risk of 1-year unplanned rehospitalization. Circulation. 2017;135(6):532-543.
Izadnegahdar M, Singer J, Lee MK, Gao M, Thompson CR, Kopec J, et al. Do younger women fare worse? sex differences in acute myocardial infarction hospitalization and early mortality rates over ten years. J Women’s Heal. 2014;23(1):10-17.
Kim LK, Yeo I, Cheung JW, Swaminathan R V, Chiu Wong S, Charitakis K, et al. Thirty-day readmission rates, timing, causes, and costs after st-segment-elevation myocardial infarction in the united states: a national readmission database analysis 2010-2014. J Am Heart Assoc. 2018;7(18):e009863.
Kundu A, O’Day K, Shaikh AY, Lessard DM, Saczynski JS, Yarzebski J, et al. Relation of atrial fibrillation in acute myocardial infarction to in-hospital complications and early hospital readmission. Am J Cardiol. 2016;117(8):1213-1218.
Narasimhan B, Patel N, Chakraborty S, Bandyopadhyay D, Sreenivasan J, Hajra A, et al. Impact of atrial fibrillation on acute coronary syndrome––analysis of in-hospital outcomes and 30-day readmissions. Curr Probl Cardiol. 2020;46(4):100764.
Doshi R, Pisipati S, Taha M, Dave M, Shah J, Adalja D, et al. Incidence, 30-day readmission rates and predictors of readmission after new onset atrial fibrillation who underwent transcatheter aortic valve replacement. Hear Lung. 2020;49(2):186-192.
Lapar DJ, Speir AM, Crosby IK, Fonner E, Brown M, Rich JB, et al. Postoperative atrial fibrillation significantly increases mortality, hospital readmission, and hospital costs. Ann Thorac Surg. 2014;98(2):527-533.
Martin GP, Kwok CS, Van Spall HGC, Volgman AS, Michos E, Parwani P, et al. Readmission and processes of care across weekend and weekday hospitalisation for acute myocardial infarction, heart failure or stroke: an observational study of the national readmission database. BMJ Open. 2019;9(8):e029667.
Rodríguez-Padial L, Elola FJ, Fernández-Pérez C, Bernal JL, Bertomeu V, Iñiguez A. Patterns of inpatient care and readmission rates (30-day, 3-month and 1-year) in myocardial infarction in spain. differences between stemi and nstemi. Rev Esp Cardiol. 2018;71(9):757-758.
Van Gelder IC, Rienstra M, Crijns HJGM, Olshansky B. Rate control in atrial fibrillation. Lancet. 2016;388(10046):818-828.
Pollack CV, Amin A, Wang T, Deitelzweig S, Cohen M, Slattery D, et al. Contemporary nstemi management: the role of the hospitalist. Hosp Pract. 2020;48(1):1-11.
Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, et al. 2014 aha/acc guideline for the management of patients with non-st-elevation acute coronary syndromes: a report of the american college of cardiology/american heart association task force on practice guidelines. Circulation. 2014;130(25):e344-e426.
Wang H, Zhao T, Wei X, Lu H, Lin X. The prevalence of 30-day readmission after acute myocardial infarction: a systematic review and meta-analysis. Clin Cardiol. 2019;42(10):889-898.
Kuehn BM. Clinics aim to improve post-icu recovery. JAMA - J Am Med Assoc. 2019;321(11):1036-1038.
Jensen JF, Thomsen T, Overgaard D, Bestle MH, Christensen D, Egerod I. Impact of follow-up consultations for icu survivors on post-icu syndrome: a systematic review and meta-analysis. Intensive Care Med. 2015;41(5):763-775.
How to Cite
Copyright (c) 2022 George Cholack, Joshua Garfein, Rachel Krallman, Delaney Feldeisen, Daniel Montgomery, Eva Kline-Rogers, Geoffrey D. Barnes, Kim Eagle, Melvyn Rubenfire, Sherry Bumpus
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to firstname.lastname@example.org
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to email@example.com